-+ 0.00%
-+ 0.00%
-+ 0.00%

Raymond James Downgrades Alignment Healthcare to Outperform, Lowers Price Target to $19

Benzinga·08/03/2026 18:50:04
Listen to the news
Raymond James analyst John Ransom downgrades Alignment Healthcare (NASDAQ:ALHC) from Strong Buy to Outperform and lowers the price target from $22 to $19.